Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117164492B details metal-free photocatalytic synthesis. Offers high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Patent CN114920775B details novel axial chiral bisindole catalyst synthesis offering high stereoselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN106478720B details a metal-free oxazoline catalyst enabling high-purity pharmaceutical intermediates with reduced environmental impact and scalable production capabilities.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.
Patent CN113511986B reveals catalyst-free aryl acetonitrile synthesis. Offers green manufacturing and supply chain reliability for pharmaceutical intermediates.
Novel nitroxide catalyst enables high-yield azlactone ring opening. Reduces costs in pharmaceutical intermediate manufacturing with superior enantioselectivity.
Novel one-pot Rh(III) catalysis for nitrogen heterocycles. High yield, mild conditions, cost-effective supply chain solution.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Novel synthesis method offers high enantioselectivity and cost reduction for asymmetric MBH and cyclization reactions in pharmaceutical manufacturing.
Novel synthesis method offers high enantioselectivity and mild conditions for asymmetric reactions, ensuring reliable supply chain and cost efficiency.
Patent CN112675920B reveals a novel monochiral ruthenium catalyst enabling efficient asymmetric hydrogenation and kinetic resolution for high-purity pharmaceutical intermediates.
Patent CN110183443A reveals a novel Rh-catalyzed oxidative coupling for high-purity indolo[3,2-c]quinoline. Achieve cost reduction in pharma intermediate manufacturing with this efficient, halogen-free route.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel axial chiral indole-furan catalyst patent CN117720537B enables mild asymmetric synthesis. Offers high enantioselectivity and cost-effective manufacturing for reliable pharma intermediate supply chains.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, suitable for pharmaceutical intermediate manufacturing.
Patent CN119019339A reveals catalyst-free quinazolinone synthesis. This method offers substantial cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN108864164B details a green, primary amine-directed synthesis of 2-alkynyl indoles using water solvent, offering cost-effective API intermediate manufacturing.
Patent CN107698590B details a novel asymmetric [3+2] cyclization for chiral carbocyclic purine nucleosides, offering high yields and enantioselectivity for reliable pharmaceutical intermediate supply.